Abstract | OBJECTIVES:
Platinum-containing chemotherapeutic drugs have high response rates yet are known to cause hypersensitivity reactions. Attempts have been made to rechallenge allergic patients with prolonged desensitization infusion regimens. CASE: CONCLUSIONS: A carboplatin desensitization regimen may allow patients with platinum-sensitive ovarian or peritoneal cancer to continue to benefit from its efficacy.
|
Authors | Tara M McElroy, Vivian E von Gruenigen, Steven E Waggoner |
Journal | Gynecologic oncology
(Gynecol Oncol)
Vol. 91
Issue 2
Pg. 435-7
(Nov 2003)
ISSN: 0090-8258 [Print] United States |
PMID | 14599880
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
|
Topics |
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects, therapeutic use)
- Carboplatin
(administration & dosage, adverse effects)
- Drug Administration Schedule
- Drug Hypersensitivity
(etiology)
- Female
- Humans
- Middle Aged
- Paclitaxel
(administration & dosage)
- Peritoneal Neoplasms
(drug therapy)
|